91 related articles for article (PubMed ID: 1702986)
21. Oral versus im administration of high-dose medroxyprogesterone acetate in pretreated patients with advanced breast cancer.
Beex L; Burghouts J; van Turnhout J; Breed W; Hillen H; Holdrinet A; Boetius G; Hoogendoorn G; Doesburg W; Verhulst M
Cancer Treat Rep; 1987 Dec; 71(12):1151-6. PubMed ID: 3690524
[TBL] [Abstract][Full Text] [Related]
22. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
23. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
Ilanchezhian S; Thangaraju M; Sachdanandam P
Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
[TBL] [Abstract][Full Text] [Related]
24. [A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer].
Sommer H; Pröhl-Steimer B; Bajetta E; Haus U; Janni W; Kay A
Zentralbl Gynakol; 2001 Oct; 123(10):557-61. PubMed ID: 11753809
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
[TBL] [Abstract][Full Text] [Related]
26. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
27. [Endocrine treatment of metastasizing breast cancer in menopausal women. A randomized comparison between tamoxifen (Nolvadex) versus tamoxifen and medroxyprogesterone acetate (Clinovir)].
Mouridsen HT; Ellemann K; Mattsson W; Palshof T; Daehnfeldt J; Rose C
Ugeskr Laeger; 1979 Jul; 141(31):2113-6. PubMed ID: 483409
[No Abstract] [Full Text] [Related]
28. Tamoxifen in the palliative treatment of advanced breast cancer. A clinical review.
Orr JD; Macdonald JA; Thomson JW
J R Coll Surg Edinb; 1979 May; 24(3):141-7. PubMed ID: 88517
[No Abstract] [Full Text] [Related]
29. Tamoxifen treatment of advanced breast carcinoma.
Roesdahl K
Acta Radiol Oncol Radiat Phys Biol; 1979; 18(3):203-8. PubMed ID: 93402
[TBL] [Abstract][Full Text] [Related]
30. Nolvadex (tamoxifen) following combination chemotherapy in progressive advanced breast cancer.
Edelstyn GA; Jeffrey L; MacRae KD
Clin Oncol; 1979 Dec; 5(4):325-30. PubMed ID: 519917
[No Abstract] [Full Text] [Related]
31. [Calusterone (7-beta, 17-alpha-dimethyltestosterone) in the palliative treatment of advanced breast cancer].
Robustelli Della Cuna G; Bernardo G; Strada MR
Minerva Med; 1977 Oct; 68(52):3555-63. PubMed ID: 74052
[TBL] [Abstract][Full Text] [Related]
32. [Tamoxifen (Nolvadex): therapeutic effect in metastasizing breast cancer].
Mouridsen HT; Palshof T; Patterson J; Battersby L
Ugeskr Laeger; 1979 Jul; 141(31):2108-13. PubMed ID: 483408
[No Abstract] [Full Text] [Related]
33. Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy.
Legha SS; Buzdar AU; Hortobagyi GN; Wiseman C; Benjamin RS; Blumenschein GR
JAMA; 1979 Jul; 242(1):49-52. PubMed ID: 448865
[TBL] [Abstract][Full Text] [Related]
34. A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.
Bratherton DG; Brown CH; Buchanan R; Hall V; Kingsley Pillers EM; Wheeler TK; Williams CJ
Br J Cancer; 1984 Aug; 50(2):199-205. PubMed ID: 6380554
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen (Nolvadex) for premenopausal patients with advanced breast cancer.
Margreiter R; Wiegele J
Breast Cancer Res Treat; 1984; 4(1):45-8. PubMed ID: 6365211
[TBL] [Abstract][Full Text] [Related]
36. Anti-oestrogen therapy of advanced mammary carcinoma.
Westerberg H; Nordenskjöld B; de Schryver A; Notter G
Acta Radiol Ther Phys Biol; 1976 Dec; 15(6):513-8. PubMed ID: 1031556
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen therapy in postmenopausal advanced breast cancer: efficacy at the primary tumor site in 46 evaluable patients.
Veronesi A; Frustaci S; Tirelli U; Galligioni E; Trovò MG; Crivellari D; Magri MD; Tumolo S; Grigoletto E
Tumori; 1981; 67(3):235-8. PubMed ID: 7281242
[TBL] [Abstract][Full Text] [Related]
38. Poor response of breast cancer to tamoxifen.
McDonald PJ; Carpenter R; Royle GT; Taylor I
Postgrad Med J; 1990 Dec; 66(782):1029-31. PubMed ID: 2084647
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen in disseminated breast cancer.
Ferrazzi E; Cartei G; De Besi P; Fornasiero A; Palù G; Paccagnella A; Sperandio P; Fosser V; Grigoletto E; Fiorentino M
Tumori; 1977; 63(5):463-8. PubMed ID: 601876
[TBL] [Abstract][Full Text] [Related]
40. Tumor lysis syndrome after tamoxifen flare.
Cech P; Block JB; Cone LA; Stone R
N Engl J Med; 1986 Jul; 315(4):263-4. PubMed ID: 3014336
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
